Fig. 2From: Cardiovascular events by different target hemoglobin levels in ESA-hyporesponsive hemodialysis patients: a multicenter, open-label, randomized controlled studyStudy design. CKD chronic kidney disease, ESA erythropoietin-stimulating agents, Hb hemoglobin, TSAT transferrin saturationBack to article page